Exploring Fatty Acids and Functional Medicine: How Fatty15 and Functional Medicine Empower Your Health
The Better Yoo Project Podcast
Hosted by Lexi Yoo, FNP-BC/CPNP
About Our Guest
Dr. Stephanie Venn-Watson is the CEO of Seraphina Therapeutics. A seasoned veterinary epidemiologist and public health scientist, Stephanie previously served at the World Health Organization and U.S. Navy. With a life-long mission of helping people (and our fellow animals) age better, Stephanie’s award winning approach to improving human and animal health has been featured on NPR, BBC, CBS, and National Geographic. In her time as CEO, Seraphina Therapeutics has been recognized for its extensive research and education on pentadecanoic acid (C15:0).
Show Notes & Resources
In this conversation, Dr. Venn-Watson explains how she was led to a groundbreaking discovery of the remarkable fatty acid, C15:0. We explore how this nutrient, and its supplement form Fatty15, holds the potential to revolutionize heart health, metabolism, and immunity, offering an alternative to traditional omega-3s without the drawbacks. We highlight the intricate mechanisms of C15:0 and its role in longevity medicine, comparing its effects to well-known agents like rapamycin and metformin. Dr. Venn-Watson also shares compelling research on C15:0’s benefits for conditions such as type 2 diabetes and fatty liver disease, emphasizing its potential to improve sleep and mood, particularly in hormone management.